Search Results - "DE VRIESE, A. S."

Refine Results
  1. 1

    The pharmacokinetics and pharmacodynamics of vancomycin in clinical practice: evidence and uncertainties by Vandecasteele, S J, De Vriese, A S, Tacconelli, E

    Published in Journal of antimicrobial chemotherapy (01-04-2013)
    “…Vancomycin has been used extensively since the late 1950s. Despite the introduction of several new valuable anti-Gram-positive antibiotics during recent years…”
    Get full text
    Journal Article
  2. 2

    Autologous transplantation of bone marrow mononuclear cells for limb ischemia in a caucasian population with atherosclerosis obliterans by Vriese, A. S. De, Billiet, J., Droogenbroeck, J. Van, Ghekiere, J., Letter, J. A. De

    Published in Journal of internal medicine (01-04-2008)
    “… Background.  Autologous transplantation of bone marrow mononuclear cells (ATBMMNC) has been used successfully in critical limb ischemia. All reported…”
    Get full text
    Journal Article
  3. 3

    The impaired renal vasodilator response attributed to endothelium-derived hyperpolarizing factor in streptozotocin - induced diabetic rats is restored by 5-methyltetrahydrofolate by DE VRIESE, A. S, VAN DE VOORDE, J, BLOM, H. J, VANHOUTTE, P. M, VERBEKE, M, LAMEIRE, N. H

    Published in Diabetologia (01-09-2000)
    “…Endothelial dysfunction contributes to the development of diabetic vascular complications. A better understanding of the pathophysiology of endothelial…”
    Get full text
    Journal Article
  4. 4

    Cytokine removal during continuous hemofiltration in septic patients by DE VRIESE, A. S, COLARDYN, F. A, PHILIPPE, J. J, VANHOLDER, R. C, DE SUTTER, J. H, LAMEIRE, N. H

    “…A potential application of the continuous renal replacement therapies is the extracorporeal removal of inflammatory mediators in septic patients. Cytokine…”
    Get full text
    Journal Article
  5. 5

    Rifampicin-associated acute renal failure: Pathophysiologic, immunologic, and clinical features by De Vriese, AS, Robbrecht, DL, Vanholder, RC, Vogelaers, DP, Lameire, NH

    Published in American journal of kidney diseases (01-01-1998)
    “…A 71-year-old woman was treated for a relapsing pulmonary tuberculosis with reinstitution of rifampicin after a medication-free interval of 2 years. After…”
    Get full text
    Journal Article
  6. 6

    Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane by DE VRIESE, An S, TILTON, Ronald G, STEPHAN, Clifford C, LAMEIRE, Norbert H

    “…Long-term peritoneal dialysis is associated with the development of functional and structural alterations of the peritoneal membrane. Long-term exposure to the…”
    Get full text
    Journal Article
  7. 7

    Early molecular events in the development of the diabetic cardiomyopathy by Mönkemann, H, De Vriese, A S, Blom, H J, Kluijtmans, L A J, Heil, S G, Schild, H H, Golubnitschaja, O

    Published in Amino acids (01-01-2002)
    “…Oxidative damage to DNA has been well documented in cardiac cells isolated from diabetic patients and rats with streptozotocin-induced diabetes mellitus (DM)…”
    Get full text
    Journal Article
  8. 8

    Endothelial dysfunction in diabetes by De Vriese, An S, Verbeuren, Tony J, Van de Voorde, Johan, Lameire, Norbert H, Vanhoutte, Paul M

    Published in British journal of pharmacology (01-07-2000)
    “…Endothelial dysfunction plays a key role in the pathogenesis of diabetic vascular disease. The endothelium controls the tone of the underlying vascular smooth…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Con: Biomarkers in glomerular diseases: putting the cart before the wheel? by De Vriese, An S, Fervenza, Fernando C

    Published in Nephrology, dialysis, transplantation (01-06-2015)
    “…Biomarkers have been increasingly sought to improve diagnosis as well as predict prognosis and/or response to therapy. However, they should not replace sound…”
    Get full text
    Journal Article
  11. 11

    Temporal IgG Subtype Changes in Recurrent Idiopathic Membranous Nephropathy by Kattah, A. G., Alexander, M. P., Angioi, A., De Vriese, A. S., Sethi, S., Cosio, F. G., Lorenz, E. C., Cornell, L. D., Fervenza, F. C.

    Published in American journal of transplantation (01-10-2016)
    “…Determination of the IgG subtypes within the immune deposits in membranous nephropathy (MN) may be helpful in the differential diagnosis. IgG4 is the…”
    Get full text
    Journal Article
  12. 12

    Long-term renal changes in the Goto-Kakizaki rat, a model of lean type 2 diabetes by Schrijvers, Bieke F., De Vriese, An S., Van de Voorde, Johan, Rasch, Ruth, Lameire, Norbert H., Flyvbjerg, Allan

    Published in Nephrology, dialysis, transplantation (01-05-2004)
    “…Background. Type 2 diabetes has become the single most frequent cause of end-stage renal disease. The Goto–Kakizaki rat is currently used as a model for lean…”
    Get full text
    Journal Article
  13. 13

    Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes by Schrijvers, B F, De Vriese, A S, Tilton, R G, Van de Voorde, J, Denner, L, Lameire, N H, Flyvbjerg, A

    Published in Hormone and metabolic research (01-01-2005)
    “…Type 2 diabetes is the most frequent cause of end-stage renal failure in many Western countries. Approximately 10-15 % of all type 2 diabetics are lean…”
    Get more information
    Journal Article
  14. 14

    Linezolid-Induced Inhibition of Mitochondrial Protein Synthesis by De Vriese, An S., Van Coster, Rudy, Smet, Joél, Seneca, Sara, Lovering, Andrew, Van Haute, Lindsey L., Vanopdenbosch, Ludo J., Martin, Jean-Jacques, Ceuterick-de Groote, Chantal, Vandecasteele, Stefaan, Boelaert, Johan R.

    Published in Clinical infectious diseases (15-04-2006)
    “…Background Linezolid is an oxazolidinone antibiotic that is increasingly used to treat drug-resistant, gram-positive pathogens. The mechanism of action is…”
    Get full text
    Journal Article
  15. 15

    NOVEL INSIGHTS IN THE TREATMENT OF DIABETIC NEPHROPATHY by Schrijvers, B.F., De Vriese, A.S.

    Published in Acta clinica belgica (English ed. Online) (01-10-2007)
    “…Diabetes is currently one of the leading causes of end-stage renal failure requiring renal replacement therapy in the Western World. About 15% to 20% of type 1…”
    Get full text
    Journal Article
  16. 16

    The role of hyperhomocysteinemia in nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF)-mediated vasodilatation by Heil, S G, De Vriese, A S, Kluijtmans, L A J, Mortier, S, Den Heijer, M, Blom, H J

    “…Hyperhomocysteinemia (HHcy) is associated with impaired endothelial-dependent vasodilatation and increased risk of atherosclerosis and thrombosis. Here, we…”
    Get full text
    Journal Article
  17. 17

    Extensive acronecrosis as a manifestation of mixed cryoglobulinaemia: a case report by van Dycke, K J M, de Vriese, A S, Matthys, E G

    Published in Acta clinica belgica (English ed. Online) (01-01-2003)
    “…Cryoglobulinaemia is a systemic disorder characterized by circulating antibodies that precipitate in the cold and resolve on rewarming. Three different types…”
    Get full text
    Journal Article
  18. 18

    Intravital microscopy: an integrated evaluation of peritoneal function and structure by De Vriese, An S., Lameire, Norbert H.

    Published in Nephrology, dialysis, transplantation (01-03-2001)
    “…Peritoneal dialysis (PD) solutions may affect various aspects of peritoneal function and structure. The present communication describes the application of an…”
    Get full text
    Journal Article Conference Proceeding
  19. 19

    Implementation of a Dose Calculator for Vancomycin to Achieve Target Trough Levels of 15-20  g/mL in Persons Undergoing Hemodialysis by Vandecasteele, S. J., De Bacquer, D., De Vriese, A. S.

    Published in Clinical infectious diseases (15-07-2011)
    “…Vancomycin is a key antibiotic for the treatment of Gram-positive bacterial infections in patients undergoing dialysis. Vancomycin has a narrow therapeutic…”
    Get full text
    Journal Article
  20. 20

    Successful treatment of renal AA amyloidosis in familial Mediterranean fever with pegylated alpha-2a interferon by Vandecasteele, S J, De Paepe, P, De Vriese, A S

    Published in Clinical nephrology (01-02-2011)
    “…Renal AA amyloidosis is a severe consequence of chronic inflammatory diseases such as familial Mediterranean fever (FMF). FMF is caused by mutations in the…”
    Get more information
    Journal Article